Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The Awareness Group (TAG) Unveils Non-FICO Driven Lease Program for Residential Projects
-
Cybeats Wins Contract with Another Top 10 Global Medical Technology Provider
-
Scryb Announces Sale of its Joint Venture Interest in Fionet Rapid Response Group for CAD$3.5 million plus a Royalty
-
Tinley's Provides Corporate Update and Announces Results of Its 2024 Annual and Special Meeting of Shareholders
-
VERSABANK TRANSITIONS CORE TEAM RESPONSIBLE FOR CANADIAN RECEIVABLE PURCHASE PROGRAM SUCCESS TO LEAD US OPPORTUNITY
-
Snipp Interactive Inc. Announces Results of Its Annual General & Special Meeting
-
Focus Universal Inc. to Showcase Universal Smart Device and Universal Smart IoT Platform at CES 2025
-
GECC Provides Year-end Review
-
Combining Assets, SMX and YBYRÁ Capital Adds the Once-Missing Link to Brazil's Manufacturing Evolution Chain
-
Merriam-Webster Announces “Polarization” as the 2024 Word of the Year
-
Improvements in Safety, Health, and Sustainability to be Explored on a New Episode of Advancements
-
Western Investment Company Completes Series of Transactions to Shift its Focus to Property and Casualty Insurance and Investment Management
-
Is the Canada-US border secure? Canadians don’t think so, Americans do
-
Perpetua Resources and Sunshine Silver Announce Agreement to Advance Domestic Antimony Supply Chain
-
METALLA ANNOUNCES APPOINTMENT OF CHRIS BEER TO BOARD OF DIRECTORS
-
Apax Funds to Sell Minority Stake in AssuredPartners to Arthur J. Gallagher & Co.
-
New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) Presented at the 2024 American Society of Hematology Meeting
-
LOMOND THERAPEUTICS REPORTS RESULTS FROM ONGOING CLINICAL STUDIES OF LONITOCLAX, A SELECTIVE BCL-2 INHIBITOR WITH BEST-IN-CLASS SELECTIVITY VERSUS BCL-XL AND NO CYP 3A4 LIABILITY
-
Secura Bio Presented New Data from its Phase 2 PRIMO Trial of Copiktra® (Duvelisib) in Relapsed or Refractory Peripheral T-cell Lymphoma and Announced Plans for its Phase 3 TERZO Trial at the 2024 Am
-
GTCR Announces Sale of AssuredPartners to Arthur J. Gallagher & Co. for $13.45 Billion
-
Nusano and GlyTherix Announce Lutetium-177 Supply Agreement
-
Riot Platforms Announces Proposed Private Offering of $500 Million of Convertible Senior Notes
-
Aircastle Delivers the First of Six 737MAX9 Aircraft to United Airlines
-
Datadog Announces Proposed Private Offering of $775 Million of Convertible Senior Notes
-
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
-
Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients
-
VERSABANK DECLARES DIVIDENDS
-
CVS Health Corporation Announces Expiration and Results of Any and All Tender Offer
-
Movement Network Foundation Announces Launch of Movement Mainnet Beta and $MOVE Token Generation Event
-
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)
-
VERSABANK FOURTH QUARTER AND FISCAL 2024 RESULTS CONTINUE TO DEMONSTRATE STRENGTH OF BUSINESS MODEL AS BANK LAUNCHES PROVEN RPP SOLUTION IN US MARKET
-
Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
-
Houston METRO awards NFI subsidiary MCI 100 D45 CRT commuter coaches
-
Wayfair Professional Unveils 2025 Design Trends
-
Startup World Cup 2025 CES Las Vegas - Win $1M Investment Prize!
-
Auron Presents New Preclinical Data for AUTX-703 in AML at ASH Annual Meeting
-
Lodging Dynamics Hospitality Group Welcomes Hospitality Veteran Lisa Carlson as Chief Operating Office
-
Chorus One Joins Northstake's ETH Validator Marketplace As Node Operator
-
BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
-
Media Alert: NightWare Launches Campaign to Disrupt Sleep
-
Sunoco LP Announces 2025 Operational and Financial Guidance and Participation in Upcoming Mizuho Power, Energy & Infrastructure Conference
-
Iron Mountain announces the election of June Yee Felix to the Board of Directors
-
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
-
Barington Capital Group Calls on Macy’s to Make Changes to Its Capital Allocation Plan to Improve Shareholder Value
-
Remote Revolutionizes Hiring with AI That Finds the Best Global Talent Seamlessly
-
Datopotamab deruxtecan granted breakthrough therapy designation in US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
-
Siyata Mobile's Versatile Bluetooth Remote Speaker Mic Gaining Sales Momentum
-
EARTHDAY.ORG RELEASES THE FIRST-OF-ITS-KIND LIVE TRACKER: MONITORING THE STATUS OF CLIMATE EDUCATION IN NATIONALLY DETERMINED CONTRIBUTIONS (NDCs) ACROSS THE WORLD
-
Flow Beverage Corp. to Attend ROTH Deer Valley Event December 11-14, 2024
-
DeepGreenX Group and Hues Capital Launch $10 Billion USD Fund to Accelerate AI, Green Energy, and Computing Power
